EXACT Sciences (EXAS) Stock: Continues Up On Pfizer (PFE) Partnership

EXACT Sciences Corporation (NASDAQ: EXAS) is having an incredibly strong start to the trading session this morning, and for good reason. The gains are ultimately following up on the strong growth yesterday as the result of a partnership between the company and the third largest pharmaceutical company in the world, Pfizer (PFE). Today, we’ll talk about: The agreement; … Read more

EXACT Sciences (EXAS) Stock: Flying On Pfizer (PFE) Collaboration

EXACT Sciences Corporation (NASDAQ: EXAS) is having an overwhelmingly strong start to the trading session in the pre-market hours this morning, and for good reason. The company announced that it has entered into an agreement with Pfizer Inc. (NYSE: PFE) surrounding its proprietary Cologuard cancer screening test. Of course, the news excited investors, sending the … Read more

EXACT Sciences (EXAS) Stock: Headed Up On Update

EXACT Sciences Corporation (NASDAQ: EXAS) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced an update with regard DNA biomarkers that may accurately detect hepatocellular carcinoma. Of course, the news excited investors, sending the stock on a run for the top. Today, we’ll talk about: … Read more

Exact Sciences (EXAS) Stock: Cologuard Is Becoming More And More Valuable

Exact Sciences (EXAS), the company behind the colorectal screening product, Cologuard, has been an interesting company to watch as of late. The stock recently caught my attention when I realized just how much Cologuard was being used. We’ll get into that in a big. For those of you who haven’t been following the company, Exact … Read more

EXACT Sciences (EXAS) Stock: Gaining On Positive Clinical Results

EXACT Sciences Corporation (NASDAQ: EXAS) EXACT Sciences is having an incredibly strong start to the trading session today. In the pre-market, the company released clinical data, causing excitement among investors and leading to strong upward movement. As a result, the stock is starting on a high note. Below, we’ll talk about what we’re seeing from … Read more